Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'vesnarinone' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cheng, JH; Kamiya, K; Kodama, I
      Carvedilol and vesnarinone: new antiarrhythmic approach in heart failure therapy

      ACTA PHARMACOLOGICA SINICA
    2. Sano, I; Kusachi, S; Murakami, T; Ninomiya, Y; Oka, T; Nunoyama, H; Kumashiro, H; Iwabu, A; Ueta, J; Tsuji, T
      OPC-8212, a quinoline derivative, counteracts the reduction in type III collagen mRNA due to lipopolysaccharides in cultured rat cardiac fibroblasts

      JAPANESE HEART JOURNAL
    3. Deswal, A; Petersen, NJ; Feldman, AM; White, BG; Mann, DL
      Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure - A report from the Vesnarinone Trial

      CHEST
    4. Skudicky, D; Bergemann, A; Sliwa, K; Candy, G; Sareli, P
      Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol - Results of a randomized study

      CIRCULATION
    5. Parmley, WW
      How many medicines do patients with heart failure need?

      CIRCULATION
    6. Pratt, CM
      Analysis of the cilostazol safety database

      AMERICAN JOURNAL OF CARDIOLOGY
    7. Fujita, M; Fujita, T; Higashino, K
      Antitumor effect of a quinolinone derivative, vesnarinone, on mouse hepatoma

      HEPATOLOGY RESEARCH
    8. MacGowan, GA
      Clinical overview of the novel inotropic agent toborinone

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    9. Aizawa, S; Hiramoto, M; Hoshi, H; Toyama, K; Shima, D; Handa, H
      Establishment of stromal cell line from an MDS RA patient which induced anapoptopic change in hematopoietic and leukemic cells in vitro

      EXPERIMENTAL HEMATOLOGY
    10. Takaya, J; Ikemoto, Y; Teraguchi, M; Nogi, S; Kobayashi, Y
      Plasma nitric oxide products correlate with cardiac index of congenital heart disease

      PEDIATRIC CARDIOLOGY
    11. Ueki, N; Taguchi, T; Takahashi, M; Adachi, M; Ohkawa, T; Amuro, Y; Hada, T; Higashino, K
      Inhibition of hyaluronan synthesis by vesnarinone in cultured human myofibroblasts

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    12. Yusuf, S
      Challenges in the conduct and interpretation of Phase II (pilot) randomized trials

      AMERICAN HEART JOURNAL
    13. Packer, M
      Current perspectives on the design of phase II trials of new drugs for thetreatment of heart failure

      AMERICAN HEART JOURNAL
    14. Fujita, M; Tsuchida, T; Fujita, T; Higashino, K
      Effects of quinolinone derivative, vesnarinone, in combination with irradiation on human lung cancer cell lines

      ONCOLOGY REPORTS
    15. Kubo, K; Matsuzaki, Y; Kato, A; Terai, S; Okita, K
      Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines

      INTERNATIONAL JOURNAL OF ONCOLOGY
    16. Fujita, M; Tsuchida, T; Higashino, K
      Effect of vesnarinone in combination with anti-cancer drugs on lung cancercell lines

      ANTI-CANCER DRUGS
    17. Okafuji, M; Ita, M; Hayatsu, Y; Shinozaki, F; Oga, A; Sasaki, K
      Identification of genetic aberrations in cell lines from oral squamous cell carcinomas by comparative genomic hybridization

      JOURNAL OF ORAL PATHOLOGY & MEDICINE
    18. Tata, PNV; Schorno, KS; Cowart, TD; Bramer, SL
      LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urine

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    19. Jager, D; Baberg, HT; Machraoui, A; Barmeyer, J
      Prediction of hemodynamics at rest and during exercise in patients with chronic heart diseases

      MEDIZINISCHE KLINIK
    20. Yokozaki, H; Ito, R; Ono, S; Hayashi, K; Tahara, E
      Effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone) on the growth of gastric cancer cell lines

      CANCER LETTERS
    21. Terra, SG; Washam, JB; Dunham, GD; Gattis, WA
      Therapeutic range of digoxin's efficacy in heart failure: What is the evidence?

      PHARMACOTHERAPY
    22. Klug, EQ
      Heart failure - An inflammatory paradigm

      SOUTH AFRICAN MEDICAL JOURNAL
    23. Jiang, H; Bielekova, B; Okazaki, H; Clarence-Smith, K; Johnson, KP; Bergey, G; Martin, R; Dhib-Jalbut, S
      The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment ofmultiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    24. Tanaka, S; Kawai, K; Nakai, S; Adachi, M; Hori, T
      Apoptosis-inducing activity and growth suppression by vesnarinone on humanglioma transplanted in nude mice

      NEUROLOGICAL RESEARCH
    25. DeMets, DL; Pocock, SJ; Julian, DG
      The agonising negative trend in monitoring of clinical trials

      LANCET
    26. Suzumura, A; Sawada, M
      Effects of vesnarinone on cytokine production and activation of murine microglia

      LIFE SCIENCES
    27. Ishiyama, S; Hiroe, M; Nishikawa, T; Shimojo, T; Hosokawa, T; Ikeda, I; Toyozaki, T; Kasajima, T; Marumo, F
      Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats

      CARDIOVASCULAR RESEARCH
    28. Honma, Y; Yamamoto-Yamaguchi, Y; Kanatani, Y
      Vesnarinone and glucocorticoids cooperatively induce G(1) arrest and have an anti-tumour effect on human nonsmall cell lung carcinoma cells grown in nude mice

      BRITISH JOURNAL OF CANCER
    29. Yoshimura, A; Yoshioka, K; Hino, M; Sugawara, H; Sakato, M; Endoh, M
      Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizingaction - 4th communication: Influence on experimentally induced ventricular arrhythmia in dogs

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    30. UNO T; TANAKA H; NAGAI H
      EFFECTS OF ISOENZYME-SELECTIVE PHOSPHODIESTERASE INHIBITORS ON BACTERIAL LIPOPOLYSACCHARIDE-INDUCED BRONCHIAL HYPERREACTIVITY IN GUINEA-PIGS

      General pharmacology
    31. Yoneda, K; Yamamoto, T; Ueta, E; Osaki, T
      Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells

      CANCER LETTERS
    32. KAWAI K; KONISHI Y; IZUMI K; SATO M; ADACHI M; HOZUMI M
      ENHANCEMENT OF ANTICANCER EFFECTS OF RADIATION AND CONVENTIONAL ANTICANCER AGENTS BY A QUINOLINONE DERIVATIVE, VESNARINONE - STUDIES ON HUMAN GASTRIC-CANCER TISSUE XENOGRAFTS IN NUDE-MICE

      Anticancer research
    33. WAGNER DR; MCTIERNAN C; SANDERS VJ; FELDMAN AM
      ADENOSINE INHIBITS LIPOPOLYSACCHARIDE-INDUCED SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA IN THE FAILING HUMAN HEART

      Circulation
    34. BRISTOW MR
      TUMOR-NECROSIS-FACTOR-ALPHA AND CARDIOMYOPATHY

      Circulation
    35. KUROSAKI K; IKEDA U; MAEDA Y; SHIMPO M; UENO S; SHIMADA K
      EFFECTS OF VESNARINONE ON NITRIC-OXIDE SYNTHESIS IN RAT CARDIAC MYOCYTES

      Cardiovascular Research
    36. KAWAMATA H; NAKASHIRO K; UCHIDA D; HINO S; OMOTEHARA F; YOSHIDA H; SATO M
      INDUCTION OF TSC-22 BY TREATMENT WITH A NEW ANTICANCER DRUG, VESNARINONE, IN A HUMAN SALIVARY-GLAND CANCER CELL

      British Journal of Cancer
    37. UCHIDA Y; KAWADA M; SAWANOBORI K; SONOKI H; INOUE K; MIZUNO K; ITOU T; TABUNOKI Y; TSUKAMOTO M; OHASHI Y; KYOTANI Y; SHIMIZU N; FUJII M; NAKAMURA M
      CARDIOVASCULAR EFFECTS OF RO-2,3,5,8,8-PENTAMETHYL-6H-FURO[2,3-E]INDOL-7-ONE HYDROCHLORIDE (UK-1745), A NOVEL CARDIOTONIC AGENT WITH VASODILATORY AND ANTIARRHYTHMIC PROPERTIES

      Arzneimittel-Forschung
    38. ADAMS KF
      POST HOC SUBGROUP ANALYSIS AND THE TRUTH OF A CLINICAL-TRIAL

      The American heart journal
    39. Shimokawa, H; Kuroiwa-Matsumoto, M; Takeshita, A
      Cytokine generation capacities of monocytes are reduced in patients with severe heart failure

      AMERICAN HEART JOURNAL
    40. SATO M; HARADA K; YURA Y; AZUMA M; KAWAMATA H; IGA H; TSUJIMOTO H; YOSHIDA H; ADACHI M
      THE TREATMENT WITH DIFFERENTIATION-INDUCING AND APOPTOSIS-INDUCING AGENT, VESNARINONE, OF A PATIENT WITH ORAL SQUAMOUS-CELL CARCINOMA

      Apoptosis
    41. SATO M; HARADA K; YURA Y; BANDO T; AZUMA M; KAWAMATA H; IGA H; YOSHIDA H
      INDUCTION OF TUMOR DIFFERENTIATION AND APOPTOSIS AND LE(Y) ANTIGEN EXPRESSION IN TREATMENT WITH DIFFERENTIATION-INDUCING AGENT, VESNARINONE, OF A PATIENT WITH SALIVARY ADENOID CYSTIC CARCINOMA

      Apoptosis
    42. YAMAMOTO M; MAEHARA Y; SAKAGUCHI Y; KUSUMOTO T; BABA H; SUGIMACHI K
      THE QUINOLINONE DERIVATIVE VESNARINONE POTENTIATES THE CYTOTOXICITY OF DOXORUBICIN IN HL-60 LEUKEMIA-CELLS

      International journal of oncology
    43. TANAKA S; NISHIHARA T; NAGASHIMA T; KAWAI K; NAKAI S; ADACHI M
      DIFFERENTIATION-INDUCING EFFECTS OF VESNARINONE ON HUMAN GLIOMA-CELLS

      Journal of clinical neuroscience
    44. NIO Y; OHMORI H; MINARI Y; HIRAHARA N; SASAKI S; TAKAMURA M; TAMURA K
      A QUINOLINONE DERIVATIVE, VESNARINONE (OPC-8212), SIGNIFICANTLY INHIBITS THE IN-VITRO AND IN-VIVO GROWTH OF HUMAN PANCREATIC-CANCER CELL-LINES

      Anti-cancer drugs
    45. VANZWIETEN PA
      CURRENT AND NEWER APPROACHES IN THE DRUG-TREATMENT OF CONGESTIVE-HEART-FAILURE

      Cardiovascular drugs and therapy
    46. SATO M; KAWAMATA H; HARADA K; NAKASHIRO K; IKEDA Y; GOHDA H; YOSHIDA H; NISHIDA T; ONO K; KINOSHITA M; ADACHI M
      INDUCTION OF CYCLIN-DEPENDENT KINASE INHIBITOR, P21(WAF1), BY TREATMENT WITH )-DIMETHOXYBENZOYL)-1-PIPERAZINYL]-2(1H)-QUINOLINE (VESNARINONE) IN A HUMAN SALIVARY CANCER CELL-LINE WITH MUTANT P53 GENE

      Cancer letters
    47. NABESHIMA R; AIZAWA S; NAKANO M; TOYAMA K; SUGIMOTO K; KAIDOW A; IMAI T; HANDA H
      EFFECTS OF VESNARINONE ON THE BONE-MARROW STROMAL CELL-DEPENDENT PROLIFERATION AND DIFFERENTIATION OF HL60 CELLS IN-VITRO

      Experimental hematology
    48. NARA N; KUROKAWA H; TOHDA S; TOMIYAMA J; NAGATA K; TANIKAWA S
      EFFECT OF VESNARINONE, A QUINOLINONE DERIVATIVE, ON THE GROWTH OF LEUKEMIC BLASTS IN ACUTE MYELOGENOUS LEUKEMIA

      Experimental hematology
    49. FUJIWARA H; ARIMA N; OTSUBO H; MATSUSHITA K; HIDAKA S; ARIMURA K; KUKITA T; YAMAGUCHI K; TANAKA H
      VESNARINONE EXHIBITS ANTITUMOR EFFECT AGAINST MYELOID-LEUKEMIA CELLS VIA APOPTOSIS

      Experimental hematology
    50. FUKUZAWA M; SATOH J; SAGARA M; MUTO G; MUTO Y; NISHIMURA S; MIYAGUCHI S; QIANG XL; SAKATA Y; NAKAZAWA T; IKEHATA F; OHTA S; TOYOTA T
      ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS SUPPRESS PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA IN-VITRO AND IN-VIVO

      Immunopharmacology
    51. HIROZANE T; MATSUMORI A; FURUKAWA Y; MATSUI S; MATOBA Y; SASAYAMA S
      PROLONGATION OF MURINE CARDIAC ALLOGRAFT SURVIVAL WITH VESNARINONE

      Journal of Molecular and Cellular Cardiology
    52. SMITH CJ; HUANG R; SUN D; RICKETTS S; HOEGLER C; DING JZ; MOGGIO RA; HINTZE TH
      DEVELOPMENT OF DECOMPENSATED DILATED CARDIOMYOPATHY IS ASSOCIATED WITH DECREASED GENE-EXPRESSION AND ACTIVITY OF THE MILRINONE-SENSITIVE CAMP-PHOSPHODIESTERASE PDE3A

      Circulation
    53. MATSUMORI A; ONO K; NISHIO R; IGATA H; SHIOI T; MATSUI S; FURUKAWA Y; IWASAKI A; NOSE Y; SASAYAMA S
      MODULATION OF CYTOKINE PRODUCTION AND PROTECTION AGAINST LETHAL ENDOTOXEMIA BY THE CARDIAC GLYCOSIDE OUABAIN

      Circulation
    54. VANDERHEIDE RS; MARSH JD
      THROUGH THE LOOKING-GLASS - A POSITIVE INOTROPIC DRUG AND ISCHEMIC PRECONDITIONING

      Circulation
    55. AIZAWA S; NAKANO M; YAGUCHI M; KURIYAMA Y; IWASE O; TOYAMA K; TANAKA K; HOSHI H; SUGIMOTO K; KAIDO A; IMAI T; NABESHIMA R; HANDA H
      POSSIBLE INVOLVEMENT OF BONE-MARROW STROMAL CELLS IN AGRANULOCYTOSIS CAUSED BY VESNARINONE TREATMENT

      Acta haematologica
    56. SATO S; TOMOYASU S; OKABEKADO J; HOZUMI M; TSURUOKA N; NAKAI S; ADACHI M; HONMA Y
      INDUCTION OF DIFFERENTIATION AND ENHANCEMENT OF VINCRISTINE SENSITIVITY OF HUMAN ERYTHROLEUKEMIA HEL CELLS BY VESNARINONE, A POSITIVE INOTROPIC AGENT

      Experimental hematology
    57. FELIX SB
      PROGNOSIS OF HEART-FAILURE - IMPACT OF ME DICAL-TREATMENT

      Zeitschrift fur Kardiologie
    58. KAMBAYASHI T; MAZUREK N; JACOB CO; WEI N; FONG M; STRASSMANN G
      VESNARINONE IS A SELECTIVE INHIBITOR OF MACROPHAGE TNF-ALPHA RELEASE

      International journal of immunopharmacology
    59. MATSUMORI A; OKADA I; SHIOI T; FURUKAWA Y; NAKAMURA T; ONO K; IWASAKI A; SASAYAMA S
      INOTROPIC AGENTS DIFFERENTIALLY INHIBIT THE INDUCTION OF NITRIC-OXIDESYNTHASE BY ENDOTOXIN IN CULTURED MACROPHAGES

      Life sciences
    60. MATSUMORI A; ONO K; SATO Y; SHIOI T; NOSE Y; SASAYAMA S
      DIFFERENTIAL MODULATION OF CYTOKINE PRODUCTION BY DRUGS - IMPLICATIONS FOR THERAPY IN HEART-FAILURE

      Journal of Molecular and Cellular Cardiology
    61. STEELE IC; NUGENT AM; MAGUIRE S; HOPER M; CAMPBELL G; HALLIDAY MI; NICHOLLS DP
      CYTOKINE PROFILE IN CHRONIC CARDIAC-FAILURE

      European journal of clinical investigation
    62. SATO M; HARADA K; BANDO T; SHIRAKAMI T; NAKASHIRO K; YOSHIDA H; NAKAI S; KAWAI K; ADACHI M
      CHARACTERISTICS OF ANTITUMOR-ACTIVITY OF DIMETHOXYBENZOYL)-1-PIPERAZINYL]-2(1H)-QUINOLINONE (VESNARINONE) AGAINST A HUMAN ADENOID SQUAMOUS CARCINOMA-FORMING CELL-LINE GROWN IN ATHYMIC NUDE-MICE

      Cancer letters
    63. UEDA K; BANASIK M; NAKAJIMA S; YOOK HY; KIDO T
      CELL-DIFFERENTIATION INDUCED BY POLY(ADP-RIBOSE) SYNTHETASE INHIBITORS

      Biochimie
    64. MATSUMORI A; SASAYAMA S
      IMMUNOMODULATING AGENTS FOR THE MANAGEMENT OF HEART-FAILURE WITH MYOCARDITIS AND CARDIOMYOPATHY-LESSONS FROM ANIMAL-EXPERIMENTS

      European heart journal
    65. KATZ AM
      CELL-DEATH IN THE FAILING HEART - ROLE OF AN UNNATURAL GROWTH-RESPONSE TO OVERLOAD

      Clinical cardiology
    66. SHIPLEY JB; HESS ML
      INOTROPIC THERAPY FOR THE FAILING MYOCARDIUM

      Clinical cardiology
    67. HATTORI Y; SO S; HATTORI S; KASAI K; SHIMODA SI
      VESNARINONE INHIBITS INDUCTION OF NITRIC-OXIDE SYNTHASE IN J774 MACROPHAGES AND RAT CARDIAC MYOCYTES IN CULTURE

      Cardiovascular Research
    68. FELDMAN AM; STROBECK JE
      QUINOLINONE DERIVATIVES IN THE MANAGEMENT OF CONGESTIVE-HEART-FAILURE

      Coronary artery disease
    69. SUGIOKA M; ITO M; MASUOKA H; ICHIKAWA K; KONISHI T; TANAKA T; NAKANO T
      IDENTIFICATION AND CHARACTERIZATION OF ISOENZYMES OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE IN HUMAN KIDNEY AND HEART, AND THE EFFECTS OF NEW CARDIOTONIC AGENTS ON THESE ISOENZYMES

      Naunyn-Schmiedeberg's archives of pharmacology
    70. MATSUI S; MATSUMORI A; SASAYAMA S
      VESNARINONE PROLONGS SURVIVAL AND REDUCES LETHALITY IN A MURINE MODELOF LETHAL ENDOTOXEMIA

      Life sciences
    71. SAITO K; NAKAYA Y; MIYOSHI Y; WAKATSUKI T; NOMURA M; SHONO M
      EFFECTS OF VESNARINONE (OPC-8212) ON CA2-ACTIVATED K-CHANNELS AND CYTOSOLIC CA2+ IN CULTURED SMOOTH-MUSCLE CELLS FROM PORCINE CORONARY-ARTERY()

      Japanese Heart Journal
    72. MATSUMORI A; SHIOI T; YAMADA T; MATSUI S; SASAYAMA S
      VESNARINONE, A NEW INOTROPIC AGENT, INHIBITS CYTOKINE PRODUCTION BY STIMULATED HUMAN BLOOD FROM PATIENTS WITH HEART-FAILURE

      Circulation
    73. TAKEYA K; ANDO H; ANDO S; YAJIMA M; NOMURA H
      RELAXING EFFECT OF VESNARINONE (OPC-8212) ON THE TRACHEAL MUSCLE STRIPS ISOLATED FROM GUINEA-PIGS

      Japanese Journal of Pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 14:58:47